Get our free email newsletter

U.S. FDA Allows Expanded Use of Medical Devices for Remote Patient Monitoring

In an action to support the healthcare system care for patients during the COVID-19 pandemic, the U.S. Food and Drug Administration (FDA) will now temporarily allow the expanded use of certain devices to enable healthcare professionals to monitor patients remotely.

According to a new Guidance document issued by the FDA on March 20th, the new policy will expand the permitted use of FDA-cleared, non-invasive, vital sign-measuring devices so that healthcare providers can use them to monitor more patients remotely. Such devices include those that measure body temperature, respiratory rate, heart rate and blood pressure.

The FDA says that the new policy remains in effect only for the duration of the current public health emergency declared by the U.S. Department of Health and Human Service (HHS), although the emergency period may be extended at the discretion of the Secretary of HHS.

- Partner Content -

A Dash of Maxwell’s: A Maxwell’s Equations Primer – Part One

Solving Maxwell’s Equations for real-life situations, like predicting the RF emissions from a cell tower, requires more mathematical horsepower than any individual mind can muster. These equations don’t give the scientist or engineer just insight, they are literally the answer to everything RF.

Read the complete text of the FDA’s new Guidance on the FDA’s enforcement policy for non-invasive remote monitoring devices is available through the Regulations.gov portal.

Related Articles

Digital Sponsors

Become a Sponsor

Discover new products, review technical whitepapers, read the latest compliance news, and check out trending engineering news.

Get our email updates

What's New

- From Our Sponsors -

Sign up for the In Compliance Email Newsletter

Discover new products, review technical whitepapers, read the latest compliance news, and trending engineering news.